Unicycive Therapeutics Files Proxy Statement Supplement
Ticker: UNCY · Form: DEFA14A · Filed: May 22, 2025 · CIK: 1766140
| Field | Detail |
|---|---|
| Company | Unicycive Therapeutics, Inc. (UNCY) |
| Form Type | DEFA14A |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, regulatory-filing
TL;DR
Unicycive updated its proxy statement for the June 9th shareholder meeting.
AI Summary
Unicycive Therapeutics, Inc. filed a Definitive Additional Materials filing (DEFA14A) on May 22, 2025, supplementing its proxy statement for the Annual Meeting of Stockholders scheduled for June 9, 2025. This filing is an amendment and supplement to previously issued proxy materials.
Why It Matters
This filing provides updated information to shareholders before the annual meeting, ensuring they have the latest details for voting on company matters.
Risk Assessment
Risk Level: low — This is a routine regulatory filing providing supplemental information for an upcoming shareholder meeting, not indicating new risks.
Key Players & Entities
- Unicycive Therapeutics, Inc. (company) — Registrant
- 0001213900-25-046551.txt (document) — Filing identifier
- June 9, 2025 (date) — Annual Meeting Date
- May 22, 2025 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for Unicycive Therapeutics, Inc.?
This filing is a Definitive Additional Materials filing, specifically a Second Amendment and Supplement to the Proxy Statement.
When is the Annual Meeting of Stockholders for Unicycive Therapeutics, Inc.?
The Annual Meeting of Stockholders is scheduled to be held on June 9, 2025.
What is the purpose of this DEFA14A filing?
The purpose is to provide a Second Amendment and Supplement to the Proxy Statement for the Annual Meeting of Stockholders.
What is the filing date of this document?
The filing date is May 22, 2025.
Who is the filer of this proxy statement?
The registrant, Unicycive Therapeutics, Inc., is filing this proxy statement.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 22, 2025 regarding Unicycive Therapeutics, Inc. (UNCY).